-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HqQFKpoxZGPvPdDkzvTWfRUkTFfGwNVwY/CVmdQnM8yrti0/FMaS1uTZGO4R3pe3 5QJgOF67lzHzyCnNyCjIKg== 0000889812-00-000616.txt : 20000211 0000889812-00-000616.hdr.sgml : 20000211 ACCESSION NUMBER: 0000889812-00-000616 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: SEROLOGICALS CORP CENTRAL INDEX KEY: 0000767673 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 582152225 STATE OF INCORPORATION: DE FISCAL YEAR END: 1227 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-46047 FILM NUMBER: 531938 BUSINESS ADDRESS: STREET 1: 780 PARK NORTH BLVD STREET 2: STE 110 CITY: CLARKSTON STATE: GA ZIP: 30021 BUSINESS PHONE: 4042965595 MAIL ADDRESS: STREET 1: 780 PARK NORTH BLVD STREET 2: STE 110 CITY: CLARKSTON STATE: GA ZIP: 30021 FORMER COMPANY: FORMER CONFORMED NAME: SEROLOGICALS HOLDINGS INC DATE OF NAME CHANGE: 19950418 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: TENOSO HAROLD J CENTRAL INDEX KEY: 0001007541 STANDARD INDUSTRIAL CLASSIFICATION: [] FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 6 DOWNSHIRE CIRCLE CITY: DECATUR STATE: GA ZIP: 30033 BUSINESS PHONE: 4046369861 MAIL ADDRESS: STREET 1: 6 DEVONSHIRE CIRCLE CITY: DECATUR STATE: GA ZIP: 30033 SC 13G 1 STATEMENT OF BENEFICIAL OWNERSHIP OMB APPROVAL ----------------------------- OMB Number: 3235-0145 Expires: August 31, 1999 Estimated average burden hours per response......14.90 ----------------------------- SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.____)* Serologicals Corporation - -------------------------------------------------------------------------------- (Name of Issuer) Common Stock - -------------------------------------------------------------------------------- (Title of Class of Securities) 817523103 - -------------------------------------------------------------------------------- (CUSIP Number) December 31, 1999 - -------------------------------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: |_| Rule 13d-1(b) |_| Rule 13d-1(c) |X| Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Potential persons who are to respond to the collection of information contained in this form are not required to respond unless this form displays a currently valid OMB control number. Page 1 of 6 pages CUSIP No. 817523103 - -------------------------------------------------------------------------------- 1 NAMES OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (entities only) Harold J. Tenoso, Ph.D. - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)(a) [ ] (b) [ ] - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION United States - -------------------------------------------------------------------------------- 5 SOLE VOTING POWER 1,181,636 NUMBER OF SHARES ---------------------------------------------------------------- BENEFICIALLY 6 SHARED VOTING POWER OWNED BY 0 EACH ---------------------------------------------------------------- REPORTING 7 SOLE DISPOSITIVE POWER PERSON 1,181,636 WITH ---------------------------------------------------------------- 8 SHARED DISPOSITIVE POWER 0 - -------------------------------------------------------------------------------- 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,181,636 - -------------------------------------------------------------------------------- 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See Instructions) [ ] - -------------------------------------------------------------------------------- 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.3% - -------------------------------------------------------------------------------- 12 TYPE OF REPORTING PERSON (See Instructions) IN - -------------------------------------------------------------------------------- Page 2 of 6 pages Item 1. (a) Name of Issuer: Serologicals Corporation (b) Address of Issuer's Principal Executive Offices: 780 Park North Boulevard Suite 110 Atlanta, GA 30021-1900 Item 2. (a)(b)(c)Name of Person Filing; Address of Principal Business Offic or, if none Residence; Citizenship: This Schedule 13G is being filed by Harold J. Tenoso, Ph.D. an individual residing at 6 Downshire Circle, Decatur, GA 30033. Harold J. Tenoso is a United States citizen. (d) Title of Class of Securities: Common Stock, par value $.01 per share (e) CUSIP Number: 817523103 Item 3. If this statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is an: (a)[ ] Broker or Dealer registered under Section 15 of the Act (b)[ ] Bank as defined in section 3(a)(6) of the Act (c)[ ] Insurance Company as defined in section 3(a)(19) of the Act (d)[ ] Investment Company registered under section 8 of the Investment Company Act of 1940 (e)[ ] An Investment Adviser in accordance with Rule 13d-1(b)(1)(ii)(E) (f)[ ] An Employee Benefit Plan or Endowment Fund in accordance with Rule 13d-1(b)(1)(ii)(F) (g)[ ] A Parent Holding Company or Control Person in accordance with Rule 13d-1(b)(ii)(G) (h)[ ] A Savings Association as defined in Section 3(b) of the Federal Deposit Insurance Act (i)[ ] A Church Plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (j)[ ] Group, in accordance with 13d-1(b)(1)(ii)(J) Page 3 of 6 pages Item 4. Ownership: (a) Amount Beneficially Owned 1,181,636 * (b) Percent of Class: 5.3% (c) Number of Shares as to which such person has: (i) sole power to vote or direct the vote - 1,181,636* (ii) shared power to vote or direct the vote - 0 (iii) sole power to dispose or direct the disposition of - 1,181,636* (iv) shared power to dispose or direct the disposition of - 0 Item 5. Ownership of Five Percent or Less of a Class: If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities check the following [ ] Item 6. Ownership of More than Five Percent on Behalf of Another Person: N/A Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company N/A Item 8. Identification and Classification of Members of the Group N/A Item 9. Notice of Dissolution of Group N/A - --------------- * Of the 1,181,636 total shares beneficially owned, 1,174,136 are issuable upon the exercise of currently exercisable options and the remainder are owned by Dr. Tenoso directly. Page 4 of 6 pages Item 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Page 5 of 6 pages Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. By:/s/ Harold J. Tenoso, Ph.D. --------------------------- Harold J. Tenoso, Ph.D. Dated: February 4, 2000 Page 6 of 6 pages -----END PRIVACY-ENHANCED MESSAGE-----